Cencora's U.S. Healthcare Solutions strength, RCA gains, and raised FY25 guidance underscore its accelerating growth momentum.
Here is how Cencora (COR) and CorMedix (CRMD) have performed compared to their sector so far this year.
Cencora (COR) reported earnings 30 days ago. What's next for the stock?
| Consumer Staples Distribution & Retail Industry | Consumer Staples Sector | Robert P. Mauch PharmD CEO | XMUN Exchange | US03073E1055 ISIN |
| US Country | 42,000 Employees | 14 Nov 2025 Last Dividend | 16 Jun 2009 Last Split | - IPO Date |
Cencora, Inc., previously known as AmerisourceBergen Corporation, represents a cornerstone in the pharmaceutical distribution industry. Established in 2001 and headquartered in Conshohocken, Pennsylvania, the company specializes in sourcing and distributing pharmaceutical products across various markets. Its operation spans a comprehensive array of services targeted at facilitating the accessibility and distribution of pharmaceuticals, healthcare products, and related services. Cencora's business operations are segmented into U.S. Healthcare Solutions and International Healthcare Solutions, each catering to a diverse range of customers and needs within the healthcare and pharmaceutical sectors.
U.S. Healthcare Solutions:
International Healthcare Solutions: